unknown
Stage
About
Barcode Nanotech develops proprietary lipid-based nanoparticles for the targeted delivery of RNA and DNA therapeutics and vaccines to specific tissues and tumors, enabling selective RNA therapeutic delivery beyond the liver.
Explore Barcode Nanotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.